|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
00950 LEE'S PHARM
Nominal 
2.000 +0.002 (+0.100%) | 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Turnover | 694,821 | 5.541% | 658,345 | 512,308 | 649,166 | 584,052 |
| Cost of Sales | (334,768) | 8.779% | (307,750) | (227,845) | (229,688) | (197,506) |
| Gross Profit | 360,053 | 2.698% | 350,595 | 284,463 | 419,478 | 386,546 |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | (253) | (419) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (488) | 104.184% | (239) | (440) | (526) | (3,311) | |
| Profit / (Loss) before Taxation | 60,675 | -0.709% | 61,108 | 27,188 | 51,795 | 2,137,279 | |
| Taxation | (10,129) | 62.350% | (6,239) | (6,279) | (24,713) | (3,377) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 16,639 | 118.675% | 7,609 | (4,792) | 1,378 | 21,298 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 67,185 | 7.534% | 62,478 | 16,117 | 28,460 | 2,155,200 | |
| 2025/06 - Interim HKD(K$) | %Chg (Compare to Interim) | 2024/06 HKD(K$) | 2023/06 HKD(K$) | 2022/06 HKD(K$) | 2021/06 HKD(K$) | |
| Net Finance Costs / (Income) | 5,218 | -8.536% | 5,705 | 4,777 | 2,316 | (531) |
| Depreciation & Amortisation | 72,150 | 2.410% | 70,452 | 77,747 | 78,536 | 70,762 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 11.410 | 7.540% | 10.610 | 2.740 | 4.830 | 366.240 |
| DPS (cts) | 2.200 | -- | 2.000 | 0.800 | 1.000 | 3.000 |
| Dividend Payout Ratio (%) | 19.281% | -- | 18.850% | 29.197% | 20.704% | 0.819% |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 3.300 | -- | 2.910 | 3.352 | 3.637 | 6.001 |
| Remarks: | Real time quote last updated: 12/09/2025 14:32 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | HKD 67,185 |
| %Change | 7.534% |
| EPS / (LPS) | HKD 0.114 |
| NBV Per Share ($) | HKD 3.300 |